FDA begins manufacturing practices initiative.

http://hoovnews.hoovers.com/fp.asp?layout=displaynews&doc_id=NR20020923670.2_d4bc0000e70e7848

	\| Subscribe \| About Hoover's \| Advertise \| Site Map \| Help \| Log Out
	<SCRIPT SRC=http://ad.doubleclick.net/adj/newscenter.com/newscenter;dcopt=ist;cui=edge;kw=nonsubscriber;sz=468x60;tile=1;ord=303384?></SCRIPT> <NOSCRIPT> <A HREF="http://ad.doubleclick.net/jump/newscenter.com/newscenter;cui=edge;kw=nonsubscriber;sz=468x60;tile=1;ord=303384?"> <IMG SRC="http://ad.doubleclick.net/ad/newscenter.com/newscenter;cui=edge;kw=nonsubscriber;sz=468x60;tile=1;ord=303384?" BORDER=0 WIDTH=468 HEIGHT=60 ALT='Click Here!'>Click Here!</A> </NOSCRIPT>


Company News

IPO News

Market News

Industry News

Free Newsletters

NewsStand

E-Mail News Alerts

UK News

for

Advanced Search (See Sample)

Lead Finder

Print This Story | E-mail This Story | Create E-mail News Alert

Back To News

FDA begins manufacturing practices initiative.

September 23, 2002 8:53am

08/26/2002

Advertisement: Explore Within This Space
	<SCRIPT SRC=http://ad.doubleclick.net/adj/newscenter.com/newscenter;cui=edge336;kw=nonsubscriber;sz=336x280;tile=5;ord=141262?></SCRIPT> <NOSCRIPT> <A HREF="http://ad.doubleclick.net/jump/newscenter.com/newscenter;cui=edge336;kw=nonsubscriber;sz=336x280;tile=5;ord=141262?"> <IMG SRC="http://ad.doubleclick.net/ad/newsnewscenter.com/newscenter;cui=edge336;kw=nonsubscriber;sz=336x280;tile=5;ord=141262?" BORDER=0 WIDTH=336 HEIGHT=280 ALT='Click Here!'>Click Here!</A> </NOSCRIPT>

The FDA has begun a major programme to upgrade and modernize its GMP requirement for drugs. The review will cover the production of veterinary and human drugs, including biological products and vaccines. The aim will be to make production processes consistent and safer. There are three goals. These are to focus more on processes that present actual risks to public health; establish quality standards that do not impede innovation or the introduction of new technologies; and to enhance the predictability in FDA's approach to quality and safety. The matter is important to the drug industry, because several drug makers have recently been charged with infringements and received fines.

Financial Times Information Limited - Asia Africa Intelligence Wire

About | Log In | Subscribe | Advertise | Site Map | Help | Feedback
Copyright © 2002, Hoover's, Inc. | Job Opportunities | NASDAQ: HOOV | Privacy Policy | Advertising Info

<SCRIPT SRC=http://ad.doubleclick.net/adj/finance.com/finance;cui=default_11;kw=nonsubscriber;sz=1x1;tile=6;ord=303384?> </SCRIPT> <NOSCRIPT> <A HREF="http://ad.doubleclick.net/jump/finance.com/finance;cui=default_11;kw=nonsubscriber;sz=1x1;tile=6;ord=303384?"> <IMG SRC="http://ad.doubleclick.net/ad/finance.com/finance;cui=default_11;kw=nonsubscriber;sz=1x1;tile=6;ord=303384?" BORDER=0 WIDTH=1 HEIGHT=1 ALT='Click Here!'>Click Here!</A> </NOSCRIPT>

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.

Primary Links

User login

FDA begins manufacturing practices initiative.